<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Anaesth</journal-id><journal-id journal-id-type="iso-abbrev">Br J Anaesth</journal-id><journal-title-group><journal-title>BJA: British Journal of Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">0007-0912</issn><issn pub-type="epub">1471-6771</issn><publisher><publisher-name>British Journal of Anaesthesia. Published by Elsevier Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7368905</article-id><article-id pub-id-type="publisher-id">S0007-0912(20)30554-7</article-id><article-id pub-id-type="doi">10.1016/j.bja.2020.07.004</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correspondence</subject></subj-group></article-categories><title-group><article-title>Opioids and the COVID-19 pandemic: does chronic opioid use or misuse increase clinical vulnerability?</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Lambert</surname><given-names>David G.</given-names></name></contrib><aff id="aff1">Department of Cardiovascular Sciences (Anaesthesia), University of Leicester, Leicester, UK</aff></contrib-group><pub-date pub-type="pmc-release"><day>19</day><month>7</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>10</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>19</day><month>7</month><year>2020</year></pub-date><volume>125</volume><issue>4</issue><fpage>e382</fpage><lpage>e383</lpage><history><date date-type="received"><day>22</day><month>6</month><year>2020</year></date><date date-type="rev-recd"><day>1</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>13</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>British Journal of Anaesthesia</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><kwd-group id="kwrds0010"><title>Keywords</title><kwd>COVID-19</kwd><kwd>opioid</kwd><kwd>opioid misuse</kwd><kwd>outcome</kwd><kwd>risk factor</kwd><kwd>social determinant</kwd></kwd-group></article-meta></front><body><p id="p0010">Editor&#x02014;Opioids have predictable analgesic actions and are widely used in many clinical settings, but they also produce unwanted side-effects including respiratory depression, tolerance and are misused. Misuse and poor opioid stewardship in the therapeutic arena are generally accepted as the underlying cause of what we describe as the &#x02018;opioid epidemic&#x02019; or &#x02018;opioid crisis&#x02019;.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> According to a UK Office for National Statistics report in 2019,<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> there were 139 845 people in contact with drug services during the 2018&#x02013;19 period; some of these will be opioid dependent, but for many this will not be a single substance misuse. Moreover, a Public Health England (PHE) report suggests 540 000 patients (retrospective) were continuously prescribed opioids for 3 yr,<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> and some of these may be opioid dependent. It is possible that some patients in the PHE report may have also made contact with drug services. Patients presenting to substance misuse services are likely to be using multiple substances so purist ascription of effect to opioid alone is problematic.</p><p id="p0015">The current coronavirus disease 2019 (COVID-19) pandemic and &#x02018;opioid epidemic&#x02019; or dare I say pandemic have clearly intersected. There is an excellent, thought-provoking opinion piece on this by Becker and Fiellin.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> The thrust of several papers on opioids and COVID-19 and the main narrative revolves around opioid prescribing, access to opioids, and sociological considerations (e.g. Dubey and colleagues<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> and Khatri and Perrone<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref>). What about the side-effects of opioids in COVID infection? Is the opioid epidemic fuelling the COVID-19 pandemic?</p><p id="p0020">As we know, opioids depress respiratory drive<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> and long-term use is immunosuppressive,<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> although direct clinical trial evidence for the latter is lacking.<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> That said, some of the seminal early work showing opioid immunosuppression is based on data showing increased infections in addicts.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> COVID infection is more likely to produce adverse outcomes in immunosuppressed patients, and this is part of the scientific evidence for shielding in this patient group. The respiratory effects of COVID-19 infection are known only too well to anaesthetists and intensivists, and ventilation of acutely unwell patients has been the mainstay of treatment and of ICU workload. Opioids may be required for pain management in COVID-19 patients,<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> and paradoxically opioids have been suggested in COVID-19 palliative care for patients experiencing the sensation of suffocation.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref>
</p><p id="p0025">In those using opioids chronically or misusing opioids, where immune depression and a propensity to respiratory depression is likely, COVID-19 infection may be all the more deadly. At the time of writing I am not aware of any published clinical data to support this prediction, although Shanthanna and colleagues<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> suggest that patients with chronic pain taking opioids might be more susceptible to COVID-19. Individuals who are opioid dependent also present with a range of additional co-morbidities, social deprivation, and homelessness. Whilst not suggesting these are a direct consequence of opioid misuse, they may be linked and combining to a major public health issue. With respect to COVID-19 protection, the UK Government defines a category of clinically vulnerable people where those with &#x02018;mild to moderate respiratory disease&#x02019; and those with a &#x02018;weakened immune system as the result of certain conditions or medicines they are taking&#x02019; are advised to take extra care.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref>
<italic>Surely those using chronic opioids therapeutically or those misusing opioids should be included in the clinically vulnerable group</italic>?</p><sec id="sec1"><title>Declarations of interest</title><p id="p0030">DGL is chair of the board of the <italic>British Journal of Anaesthesia</italic>. DGL is also a non-executive director of Cellomatics, a small- or medium-sized enterprise contract research organisation.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Hemmings</surname><given-names>H.C.</given-names><suffix>Jr.</suffix></name><name><surname>Lambert</surname><given-names>D.G.</given-names></name></person-group><article-title>The good, the bad, and the ugly: the many faces of opioids</article-title><source>Br J Anaesth</source><volume>122</volume><year>2019</year><fpage>705</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">31005244</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="other" id="sref2"><article-title>Adult substance misuse treatment statistics 2018 to 2019: report</article-title><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://www.gov.uk/government/publications/substance-misuse-treatment-for-adults-statistics-2018-to-2019/adult-substance-misuse-treatment-statistics-2018-to-2019-report" id="intref0010">https://www.gov.uk/government/publications/substance-misuse-treatment-for-adults-statistics-2018-to-2019/adult-substance-misuse-treatment-statistics-2018-to-2019-report</ext-link></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="other" id="sref3"><article-title>Dependence and withdrawal associated with some prescribed medicines</article-title><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/829777/PHE_PMR_report.pdf" id="intref0015">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/829777/PHE_PMR_report.pdf</ext-link></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>W.C.</given-names></name><name><surname>Fiellin</surname><given-names>D.A.</given-names></name></person-group><article-title>When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis</article-title><source>Ann Intern Med</source><volume>173</volume><year>2020</year><fpage>59</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">32240291</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Dubey</surname><given-names>M.J.</given-names></name><name><surname>Ghosh</surname><given-names>R.</given-names></name><name><surname>Chatterjee</surname><given-names>S.</given-names></name><name><surname>Biswas</surname><given-names>P.</given-names></name><name><surname>Chatterjee</surname><given-names>S.</given-names></name><name><surname>Dubey</surname><given-names>D.</given-names></name></person-group><article-title>COVID-19 and addiction</article-title><source>Diabetes Metab Syndr</source><volume>14</volume><year>2020</year><fpage>81723</fpage></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Khatri</surname><given-names>U.G.</given-names></name><name><surname>Perrone</surname><given-names>J.</given-names></name></person-group><article-title>Opioid use disorder and COVID-19: crashing of the crises</article-title><source>J&#x000a0;Addict Med</source><year>2020</year><pub-id pub-id-type="doi">10.1097/ADM.0000000000000684</pub-id><comment>Advance Access published on May 12, 2020</comment></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Algera</surname><given-names>M.H.</given-names></name><name><surname>Kamp</surname><given-names>J.</given-names></name><name><surname>van der Schrier</surname><given-names>R.</given-names></name></person-group><article-title>Opioid-induced respiratory depression in humans: a review of pharmacokinetic&#x02013;pharmacodynamic modelling of reversal</article-title><source>Br J Anaesth</source><volume>122</volume><year>2019</year><fpage>e168</fpage><lpage>e179</lpage><pub-id pub-id-type="pmid">30915997</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Al-Hashimi</surname><given-names>M.</given-names></name><name><surname>Scott</surname><given-names>S.W.</given-names></name><name><surname>Thompson</surname><given-names>J.P.</given-names></name><name><surname>Lambert</surname><given-names>D.G.</given-names></name></person-group><article-title>Opioids and immune modulation: more questions than answers</article-title><source>Br J Anaesth</source><volume>111</volume><year>2013</year><fpage>80</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">23794649</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Plein</surname><given-names>L.M.</given-names></name><name><surname>Rittner</surname><given-names>H.L.</given-names></name></person-group><article-title>Opioids and the immune system &#x02014; friend or foe</article-title><source>Br J Pharmacol</source><volume>175</volume><year>2018</year><fpage>2717</fpage><lpage>2725</lpage><pub-id pub-id-type="pmid">28213891</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Hussey</surname><given-names>H.H.</given-names></name><name><surname>Katz</surname><given-names>S.</given-names></name></person-group><article-title>Infections resulting from narcotic addiction; report of 102 cases</article-title><source>Am J Med</source><volume>9</volume><year>1950</year><fpage>186</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">15432465</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>H.I.</given-names></name><name><surname>Corner</surname><given-names>E.</given-names></name><name><surname>Colvin</surname><given-names>L.A.</given-names></name></person-group><article-title>Chronic pain after COVID-19: implications for rehabilitation</article-title><source>Br J Anaesth</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.bja.2020.05.021</pub-id><comment>Advance Access published on May 31, 2020</comment></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Kiserud</surname><given-names>Y.</given-names></name><name><surname>Rosland</surname><given-names>J.H.</given-names></name></person-group><article-title>Relieving the sensation of suffocation in patients dying with COVID-19</article-title><source>Tidsskr Nor Legeforen</source><year>2020</year><pub-id pub-id-type="doi">10.4045/tidsskr.20.0317</pub-id><comment>Advance Access published on May 26, 2020</comment></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Shanthanna</surname><given-names>H.</given-names></name><name><surname>Strand</surname><given-names>N.H.</given-names></name><name><surname>Provenzano</surname><given-names>D.A.</given-names></name></person-group><article-title>Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel</article-title><source>Anaesthesia</source><volume>75</volume><year>2020</year><fpage>935</fpage><lpage>944</lpage><pub-id pub-id-type="pmid">32259288</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="other" id="sref14"><article-title>Staying alert (and social distancing)</article-title><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.gov.uk/government/publications/staying-alert-and-safe-social-distancing/staying-alert-and-safe-social-distancing" id="intref0020">https://www.gov.uk/government/publications/staying-alert-and-safe-social-distancing/staying-alert-and-safe-social-distancing</ext-link></comment></element-citation></ref></ref-list></back></article>